ArticleFrontiers in immunology2024

Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report.

Zhuixing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.